Regulation of Aberrant Protein Production

异常蛋白质生产的调节

基本信息

项目摘要

ABSTRACT Defective proteins result from mutations, mistakes of transcription, stress, and other factors. These aberrant proteins are often toxic and cause a number of human diseases. There are several quality control (QC) pathways in the cells: nonsense-mediated, no-stop, and no-go decays for defective mRNAs, and the ubiquitin/proteasome system for already synthesized misfolded proteins. Recently, we discovered a new QC pathway called Regulation of Aberrant Protein Production (RAPP). RAPP is a preemptive QC, it monitors proteins during their synthesis at the ribosome, senses defective proteins and degrades their mRNA templates. It is the first example of transferring information about aberrant proteins to mRNA degradation machinery. Normally, nascent polypeptides emerged from the ribosome exit tunnel interact with targeting or folding factors. When a mutation prevents these interactions, the Ago2 protein, a sensor in the RAPP response, detects the loss of these important interactions and triggers mRNA degradation. Surprisingly, Ago2 endonuclease activity is not required in the process. Thus, the molecular mechanism of RAPP is not well understood, very little is known about its mRNA degradation machinery and its substrates. The proposed project will fill these gaps in knowledge. Our hypothesis is that RAPP is a general protein quality control pathway that consists of three major steps: detection of an aberrant nascent chain complex, translational repression, and formation of specialized cytoplasmic foci for degradation of the aberrant mRNA. Our specific aims are designed to test this hypothesis and directed to (1) elucidate the mechanism by which protein expression is down-regulated in RAPP, and (2) determine whether RAPP is a general mechanism of protein quality control for secretory and membrane proteins in mammalian cells. The proposal involves application of comprehensive in vivo and in vitro approaches, including our unique technology, iPINCH, for identification of Proteins Interacting with Nascent Chains. Determining the scope and mechanism of RAPP will impact the field of protein quality control research by providing a better understanding of cellular defense against erroneous and potentially toxic proteins.
摘要

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SRPassing Co-translational Targeting: The Role of the Signal Recognition Particle in Protein Targeting and mRNA Protection.
Defective Human SRP Induces Protein Quality Control and Triggers Stress Response.
缺陷人类SRP诱导蛋白质质量控​​制,并触发压力反应。
  • DOI:
    10.1016/j.jmb.2022.167832
  • 发表时间:
    2022-11-30
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Tikhonova, Elena B.;Guarnizo, Sneider Alexander Gutierrez;Kellogg, Morgana K.;Karamyshev, Alexander;Dozmorov, Igor M.;Karamysheva, Zemfira N.;Karamyshev, Andrey L.
  • 通讯作者:
    Karamyshev, Andrey L.
Aberrant protein targeting activates quality control on the ribosome.
Pathogenic signal peptide variants in the human genome.
Signal Recognition Particle in Human Diseases.
  • DOI:
    10.3389/fgene.2022.898083
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrey L Karamyshev其他文献

Andrey L Karamyshev的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrey L Karamyshev', 18)}}的其他基金

Development of an Anti-Cancer Approach Through a Novel Pathway of Translational Regulation
通过转化调控的新途径开发抗癌方法
  • 批准号:
    10727837
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Regulation of Aberrant Protein Production
异常蛋白质生产的调节
  • 批准号:
    10019580
  • 财政年份:
    2019
  • 资助金额:
    $ 30.6万
  • 项目类别:
Regulation of Aberrant Protein Production
异常蛋白质生产的调节
  • 批准号:
    10248453
  • 财政年份:
    2019
  • 资助金额:
    $ 30.6万
  • 项目类别:

相似国自然基金

分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 批准年份:
    2020
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 批准年份:
    2019
  • 资助金额:
    20.5 万元
  • 项目类别:
    青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
  • 批准号:
    81402419
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
  • 批准号:
    81271563
  • 批准年份:
    2012
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
  • 批准号:
    31272541
  • 批准年份:
    2012
  • 资助金额:
    82.0 万元
  • 项目类别:
    面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
  • 批准号:
    31271248
  • 批准年份:
    2012
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
  • 批准号:
    81160050
  • 批准年份:
    2011
  • 资助金额:
    49.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Diversity of neural stem cells lineages and temporal scaling in mammalian complex brain formation
哺乳动物复杂大脑形成中神经干细胞谱系的多样性和时间尺度
  • 批准号:
    23H00383
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
血细胞和光脑复合物 IV 氧化还原态在猪 CO 中毒模型中的应用及线粒体治疗的评价
  • 批准号:
    10734741
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Diversification of the mechanotransduction complex in vestibular hair cells
前庭毛细胞中机械转导复合体的多样化
  • 批准号:
    10734358
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Genetic interactions among targets of master regulator genes as drivers of complex behavior in Drosophila intestinal stem cells
主调节基因靶标之间的遗传相互作用作为果蝇肠道干细胞复杂行为的驱动因素
  • 批准号:
    10629992
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Developing novel label-free technologies for studying drug molecules and their ability to induce protein complex formation in cells
开发新型无标记技术来研究药物分子及其诱导细胞中蛋白质复合物形成的能力
  • 批准号:
    2886861
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Studentship
Archaea gene cataloguing-based reconstruction of evolution from simple to complex cells
基于古细菌基因编目重建从简单细胞到复杂细胞的进化
  • 批准号:
    22KF0418
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Photo-information analysis of stable and transformative lanthanide complex in cancer cells
癌细胞中稳定和转化的稀土配合物的光信息分析
  • 批准号:
    23K17925
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The MYC/MIZ-1 complex in germinal center B cells and B cell lymphomagenesis
生发中心 B 细胞和 B 细胞淋巴瘤发生中的 MYC/MIZ-1 复合物
  • 批准号:
    484358
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Operating Grants
Direct generation of complex genetically-modified mouse models via embryonic stem cells
通过胚胎干细胞直接生成复杂的转基因小鼠模型
  • 批准号:
    10589018
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
Analysis of the mechanism by which leaf epidermal cells develop complex shapes.
分析叶表皮细胞形成复杂形状的机制。
  • 批准号:
    22K06264
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了